A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinomaJONES, Robert J; HAWKINS, Robert E; EATOCK, Martin M et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 3, pp 435-441, issn 0344-5704, 7 p.Article

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid TumorsPACEY, Simon; WILSON, Richard H; PEACHEY, Heidi et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1561-1570, issn 1078-0432, 10 p.Article

Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liverSHARMA, Ricky A; EATOCK, Martin M; TWELVES, Christopher J et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 3, pp 197-201, issn 0344-5704Article

Non-infusional 5-fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinomaPENTHEROUDAKIS, George; LIM, K. Chee; DUNLOP, David J et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 7, pp 855-861, issn 0284-186XArticle